Cargando…

BAY 41-2272 Attenuates CTGF Expression via sGC/cGMP-Independent Pathway in TGFβ1-Activated Hepatic Stellate Cells

Activation of hepatic stellate cells (HSCs) is a critical pathogenic feature of liver fibrosis and cirrhosis. BAY 41-2272 is a canonical non-nitric oxide (NO)-based soluble guanylyl cyclase (sGC) stimulator that triggers cyclic guanosine monophosphate (cGMP) signaling for attenuation of fibrotic dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Po-Jen, Kuo, Liang-Mou, Wu, Yi-Hsiu, Chang, Yu-Chia, Lai, Kuei-Hung, Hwang, Tsong-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554962/ https://www.ncbi.nlm.nih.gov/pubmed/32899801 http://dx.doi.org/10.3390/biomedicines8090330

Ejemplares similares

Relaxant effect of BAY 41-2272 and BAY 58-2667 in the gastrointestinal tract of apo-sGC mice
por: Cosyns, Sarah, et al.
Publicado: (2011)

NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272
por: Becker, Eva Maria, et al.
Publicado: (2001)

Antihypertrophic actions of NO-independent soluble guanylyl cyclase (sGC) ligands BAY 41-2272 and BAY 58-2667 in vitro
por: Ritchie, Rebecca, et al.
Publicado: (2009)

Mapping of the sGC Stimulator BAY 41-2272 Binding Site on H-NOX Domain and Its Regulation by the Redox State of the Heme
por: Makrynitsa, Garyfallia I., et al.
Publicado: (2022)

Is Innervation of the Neuromuscular Junction at the Diaphragm Modulated by sGC/cGMP Signaling?
por: Lukáčová, Nadežda, et al.
Publicado: (2020)

Inhibition of ferrochelatase impairs vascular eNOS/NO and sGC/cGMP signaling
por: Zhang, Bin, et al.
Publicado: (2018)

The Role of NO/sGC/cGMP/PKG Signaling Pathway in Regulation of Platelet Function
por: Gambaryan, Stepan
Publicado: (2022)

Vasorelaxation Induced by a New Naphthoquinone-Oxime is Mediated by NO-sGC-cGMP Pathway
por: Dantas, Bruna P. V., et al.
Publicado: (2014)

Treatment of pediatric pulmonary arterial hypertension: A focus on the NO‐sGC‐cGMP pathway
por: Beghetti, Maurice, et al.
Publicado: (2019)

Mechanisms of relaxant activity of BAY 41-2272 in rat tracheal smooth muscle in vitro
por: Toque, Haroldo AF, et al.
Publicado: (2009)

Effect of L-carnitine supplementation on the sGC/cGMP pathway in vascular relaxing responses from exercised rats
por: Priviero, Fernanda BM, et al.
Publicado: (2009)

Nitrite mediated vasorelaxation in human chorionic plate vessels is enhanced by hypoxia and dependent on the NO-sGC-cGMP pathway
por: Tropea, Teresa, et al.
Publicado: (2018)

The sGC stimulator BAY 41-8543 in a rat model of hypertension-induced heart failure
por: Haase, N, et al.
Publicado: (2015)

Phosphodiesterases Regulate BAY 41-2272-Induced VASP Phosphorylation in Vascular Smooth Muscle Cells
por: Adderley, Shaquria P., et al.
Publicado: (2012)

The soluble guanylyl cyclase stimulator BAY 41-2272 increases differentiation and function of brown adipocytes
por: Etzrodt, Jennifer, et al.
Publicado: (2013)

BAY 41-2272 activates host defence against local and disseminated Candida albicans infections
por: Soeiro-Pereira, Paulo Vítor, et al.
Publicado: (2015)

L-arginine supplementation improves aortic vascular relaxation via NO-independent sGC/cGMP signaling in exercised rats
por: Zanesco, Angelina, et al.
Publicado: (2009)

Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC/cGMP/PKG Translocation in Experimental Vasospasm
por: Chang, Chih-Zen, et al.
Publicado: (2014)

Corrigendum to “Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC/cGMP/PKG Translocation in Experimental Vasospasm”
por: Chang, Chih-Zen, et al.
Publicado: (2016)

Hypoxia/Reoxygenation of Rat Renal Arteries Impairs Vasorelaxation via Modulation of Endothelium-Independent sGC/cGMP/PKG Signaling
por: Braun, Diana, et al.
Publicado: (2018)

A systems biology approach to cGMP suggests a prominent role for sGC in stroke: Validation by mechanism-based activation of apo-sGC in non-steal dosing coveys neuroprotection and increased survival
por: Casas, Ana I, et al.
Publicado: (2015)

Helicid Reverses the Effect of Overexpressing NCALD, Which Blocks the sGC/cGMP/PKG Signaling Pathway in the CUMS-Induced Rat Model
por: Zhang, Xiao-Tong, et al.
Publicado: (2021)

Age, noise and cGMP: Pharmacological activation of soluble guanylyl cyclase (sGC) interacts with the progression of age related and noise induced hearing loss
por: Rüttiger, Lukas, et al.
Publicado: (2015)

Retracted: Helicid Reverses the Effect of Overexpressing NCALD, Which Blocks the sGC/cGMP/PKG Signaling Pathway in the CUMS-Induced Rat Model
por: Healthcare Engineering, Journal of
Publicado: (2023)

Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis
por: Schinner, Elisabeth, et al.
Publicado: (2017)

The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate
por: Wang, Chao, et al.
Publicado: (2016)

Targeted Delivery of Soluble Guanylate Cyclase (sGC) Activator Cinaciguat to Renal Mesangial Cells via Virus-Mimetic Nanoparticles Potentiates Anti-Fibrotic Effects by cGMP-Mediated Suppression of the TGF-β Pathway
por: Fleischmann, Daniel, et al.
Publicado: (2021)

Platelet inhibitory effects of the NO independent sGC stimulator riociguat (Bay 63-2561)
por: Reiss, Cora, et al.
Publicado: (2013)

Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC
por: Becker-Pelster, Eva M., et al.
Publicado: (2022)

Structural insights into sGC
por: Akker, Focco van den, et al.
Publicado: (2009)

The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes
por: Rosa, Irene, et al.
Publicado: (2022)

Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy
por: Krishnan, Shalini Murali, et al.
Publicado: (2021)

sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH
por: Hall, Katherine C., et al.
Publicado: (2019)

Molecular aspects of sGC regulation
por: Marletta, Michael A, et al.
Publicado: (2011)

Targeting native and apo-sGC
por: Struthers, Mary, et al.
Publicado: (2013)

sGC redox regulation and asthma
por: Stuehr, Dennis J, et al.
Publicado: (2015)

NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009)

cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015)

Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
por: Wen, Lai, et al.
Publicado: (2013)

Transient kinetics of a cGMP-dependent cGMP-specific phosphodiesterase from Dictyostelium discoideum
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_p4srim2t77k4lnjg9r1279s1qo